Chunbo (27828) investor relations material

Executive summary

• Revenue for H1 2026 was KRW 91.8 billion, down 31% year-over-year, with a net loss of KRW 12.3 billion compared to a net loss of KRW 32.3 billion in H1 2025.

• Operating loss was KRW 7.2 billion, reversing from an operating profit of KRW 5.7 billion in H1 2025.

• The company operates in electronic materials, secondary battery materials, pharmaceuticals, and fine chemicals, with secondary battery materials as the largest segment.

Financial highlights

• Gross profit margin turned negative at -3.3% in H1 2026, compared to 15.1% in H1 2025.

• Cash and cash equivalents at period-end were KRW 16.0 billion, up slightly from KRW 15.5 billion at the end of 2025.

• Total assets stood at KRW 907.9 billion, with equity of KRW 482.4 billion and liabilities of KRW 425.5 billion.

• Net debt to capital ratio increased to 44.7% from 43.0% at the end of 2025.

• R&D expenses for H1 2026 were KRW 1.5 billion, representing 1.66% of sales.

Outlook and guidance

• The company plans to maintain a flexible dividend policy, prioritizing shareholder returns and financial soundness.

• Future dividend levels will be adjusted based on actual business performance, cash generation, and market conditions.